DECEMBER 31 IT ALL ENDS!
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
Before we talk about December 31st, the FDA, or compounded weight-loss medications, this episode starts with something most people misunderstand:
What compounding pharmacies are actually for.
Joanne begins by explaining the original and ongoing role of compounding pharmacies — using hormone replacement therapy (HRT) as a clear, long-standing example — before addressing why compounded GLP-1 medications existed temporarily and why that chapter is now closing.
This context matters, because without it, everything happening right now sounds dramatic when it really isn’t.
🔍 What’s Covered in This Episode 🧪 What Compounding Pharmacies Actually Do-
Why compounding pharmacies exist in the first place
-
How compounding is meant to customize medication, not replace FDA-approved drugs
-
A clear explanation of compounded HRT, including:
-
Doses that do not exist in FDA-approved products
-
Patients who need amounts between standard commercial doses
-
Delivery methods or formulations that FDA products don’t offer
-
Why testosterone for women is commonly compounded
-
-
Why compounded HRT continues to be appropriate and legal: because FDA products cannot meet every individual dosing or formulation need
-
Why compounded GLP-1 medications were legally allowed during shortages
-
How compounding pharmacies were permitted to fill a supply gap, not a medical customization gap
-
Why this was always intended to be temporary
-
The difference between individualized medical compounding and mass-market convenience compounding
-
What actually changed when GLP-1 shortages ended
-
Why compounding pharmacies were given a wind-down period
-
Why December 31st became a common operational cutoff
-
Why this is not a ban, crackdown, or conspiracy — but a return to standard FDA rules
-
Why compounding still exists — but within narrow, patient-specific boundaries
-
Why GLP-1 mass compounding no longer fits the legal definition once supply stabilized
-
How fear-based “stock up now” messaging misses the point
-
Why medication can be a tool — but not a substitute for education, physiology, and behavior
Joanne also shares her recent reaction to a change in her thyroid medication, using it as a real-world example of why individualized dosing matters — and why nuance in medicine is often lost in online conversations.
📅 Program Dates for 2026All program dates for 2026 are now set.
View the full schedule here: 👉 www.joannelee2026.com
🧬 One-on-One Peptide ConsultationsIf you’d like to book a private consultation regarding peptide use, you can contact Joanne directly:
📧 www.5dayshred.com
🧠 The Victory VaultA foundational program covering body composition, decision-making, and long-term success. 👉 www.yourvictoryvault.com
These programs give you a clear feel for how Joanne coaches before stepping into more advanced or longer-term work.
🎧 Final ThoughtThis episode isn’t about losing access — it’s about understanding how compounding was meant to work, why GLP-1 compounding filled a temporary gap, and why returning to clear boundaries actually protects patients.
Clarity beats panic. Education beats outrage.